Breaking News, Collaborations & Alliances

WuXi XDC Taps Schreiner MediPharm for ADC Drug Label Solution

Schreiner MediPharm developed a solution with integrated UV and light protection that is ideally suited to transparent vials.

Author Image

By: Charlie Sternberg

Associate Editor

WuXi XDC, a contract research, development, and manufacturing organization (CRDMO) headquartered in China, recently tapped Shreiner MediPharm to support a clinical trial for an ADC drug that required a reliable label solution.   A light-sensitive active ingredient filled into vials as a lyophilized powder needed to be effectively protected against external influences. WuXi XDC found the solution through cooperation with Schreiner MediPharm by implementing a Light-Protect-Label that perfectly m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters